X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (323) 323
life sciences & biomedicine (314) 314
humans (313) 313
hematology (228) 228
female (195) 195
transplantation (182) 182
adult (169) 169
middle aged (158) 158
male (135) 135
aged (103) 103
immunology (103) 103
stem cells (99) 99
hematology, oncology and palliative medicine (97) 97
oncology (97) 97
abridged index medicus (68) 68
hematopoietic stem cell transplantation (68) 68
treatment outcome (63) 63
adolescent (62) 62
cancer (60) 60
hematopoietic stem cells (57) 57
young adult (55) 55
transplantation, homologous (49) 49
transplantation, autologous (48) 48
leukemia (45) 45
retrospective studies (45) 45
antineoplastic combined chemotherapy protocols - therapeutic use (43) 43
fetal blood - cytology (41) 41
breast neoplasms - therapy (40) 40
prognosis (40) 40
analysis (39) 39
child (39) 39
disease-free survival (38) 38
hematopoietic stem cell transplantation - methods (38) 38
medicine, research & experimental (38) 38
research & experimental medicine (38) 38
survival analysis (38) 38
care and treatment (37) 37
animals (36) 36
cord blood (36) 36
bone marrow (35) 35
stem cell transplantation (35) 35
survival rate (35) 35
combined modality therapy (34) 34
chemotherapy (33) 33
t cells (33) 33
transplantation conditioning - methods (33) 33
recurrence (32) 32
breast neoplasms - drug therapy (30) 30
bone marrow transplantation (29) 29
immunotherapy (29) 29
hematopoietic stem cell transplantation - adverse effects (28) 28
hemic and lymphatic diseases (28) 28
mice (28) 28
risk factors (28) 28
t-lymphocytes - immunology (28) 28
cells, cultured (27) 27
hematologic neoplasms - therapy (27) 27
health aspects (26) 26
research (26) 26
graft vs host disease - prevention & control (25) 25
cell biology (24) 24
cord blood stem cell transplantation - methods (24) 24
cyclophosphamide - administration & dosage (23) 23
antineoplastic agents - therapeutic use (22) 22
child, preschool (22) 22
follow-up studies (22) 22
remission induction (22) 22
antineoplastic combined chemotherapy protocols - administration & dosage (21) 21
biotechnology & applied microbiology (21) 21
graft vs host disease - etiology (21) 21
microbiology (21) 21
prospective studies (21) 21
surgical procedures, operative (21) 21
transplants & implants (21) 21
dose-response relationship, drug (20) 20
hematopoietic stem cells - cytology (20) 20
leukemia, myeloid, acute - therapy (20) 20
mortality (20) 20
patients (20) 20
transplantation conditioning (20) 20
antigens (19) 19
antineoplastic combined chemotherapy protocols - adverse effects (19) 19
biochemistry (19) 19
breast neoplasms - pathology (19) 19
carmustine - administration & dosage (19) 19
cell & tissue engineering (19) 19
clinical trials (19) 19
culture media (19) 19
time factors (19) 19
vidarabine - analogs & derivatives (19) 19
high-dose chemotherapy (18) 18
acute myeloid leukemia (17) 17
beer (17) 17
chemistry (17) 17
compositions thereof (17) 17
enzymology (17) 17
metallurgy (17) 17
microorganisms or enzymes (17) 17
mutation or genetic engineering (17) 17
propagating, preserving or maintaining microorganisms (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 12/2012, Volume 367, Issue 24, pp. 2305 - 2315
Journal Article
The New England journal of medicine, ISSN 1533-4406, 10/2018, Volume 379, Issue 15, pp. 1443 - 1451
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2016, Volume 137, Issue 5, pp. 1498 - 1505.e1
Journal Article
PloS one, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, pp. e76781 - e76781
..., Richard E. Champlin 1, Catherine M. Bollard 2, Elizabeth J. Shpall 1 Introduction Multiple myeloma (MM) is the second most common hematologic malignancy in adults [1... 
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | Cell Proliferation | Coculture Techniques | Humans | Multiple Myeloma - immunology | Interleukin Receptor Common gamma Subunit - immunology | NK Cell Lectin-Like Receptor Subfamily D - immunology | NK Cell Lectin-Like Receptor Subfamily C - immunology | Multiple Myeloma - therapy | Interleukin-2 - immunology | Killer Cells, Natural - immunology | Cell Culture Techniques | CD56 Antigen - immunology | Cytotoxicity, Immunologic - drug effects | CD56 Antigen - metabolism | Fetal Blood - immunology | NK Cell Lectin-Like Receptor Subfamily C - metabolism | Cells, Cultured | Fetal Blood - cytology | Fetal Blood - metabolism | Mice, SCID | Xenograft Model Antitumor Assays - methods | Antigen-Presenting Cells - immunology | CD3 Complex - metabolism | Interleukin Receptor Common gamma Subunit - genetics | Mice, Knockout | Interleukin Receptor Common gamma Subunit - deficiency | Microscopy, Confocal | Multiple Myeloma - pathology | Animals | CD3 Complex - immunology | K562 Cells | Cell Line, Tumor | Interleukin-2 - pharmacology | Mice, Inbred NOD | Mice | Killer Cells, Natural - metabolism | Cytotoxicity, Immunologic - immunology | NK Cell Lectin-Like Receptor Subfamily D - metabolism | Antigens | Killer cells | Cell culture | Pediatrics | Transcription factors | Transplants & implants | Toxicity | Leukemia | Multiple myeloma | Cytotoxicity | Immunological synapses | Immunity | Blood | NKG2 antigen | Receptors | Interleukin 2 | Cord blood | Cryopreservation | Immunotherapy | Bone marrow | Biocompatibility | Natural killer cells | CD56 antigen | Expansion | Immunoglobulins | Cytokines | CD3 antigen | Permeability | Medicine | Studies | Stem cells | Ligands | Umbilical cord | Gene therapy | Synapses | Cancer | Index Medicus
Journal Article
Molecular therapy, ISSN 1525-0016, 08/2017, Volume 25, Issue 8, pp. 1769 - 1781
Journal Article
Cancer biology & therapy, ISSN 1538-4047, 10/2014, Volume 13, Issue 10, pp. 858 - 870
Overcoming resistance to chemotherapy is the main therapeutic challenge in the treatment of acute lymphocytic leukemia (ALL). Interactions between leukemia... 
microenvironment | ALL | hypoxia | chemoresistance | HIF-1α | Binding | Proteins | Landes | Calcium | Bioscience | Biology | Cell | Cycle | Cancer | Organogenesis | Hypoxia | Microenvironment | Chemoresistance | Life Sciences & Biomedicine | Oncology | Science & Technology | Coculture Techniques | Humans | Middle Aged | Child, Preschool | Tumor Microenvironment | Infant | Male | Precursor Cell Lymphoblastic Leukemia-Lymphoma - mortality | Transplantation, Heterologous | Extracellular Signal-Regulated MAP Kinases - metabolism | Glycolysis - drug effects | Proto-Oncogene Proteins c-akt - genetics | Cell Hypoxia | TOR Serine-Threonine Kinases - antagonists & inhibitors | Young Adult | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Precursor Cell Lymphoblastic Leukemia-Lymphoma - metabolism | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Bone Marrow - metabolism | Aged, 80 and over | Adult | Female | Proto-Oncogene Proteins c-akt - metabolism | Child | Gene Expression | Ribosomal Protein S6 Kinases, 70-kDa - metabolism | Signal Transduction | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Gene Expression Regulation, Leukemic - drug effects | Ribosomal Protein S6 Kinases, 70-kDa - genetics | Precursor Cell Lymphoblastic Leukemia-Lymphoma - genetics | Drug Resistance, Neoplasm - genetics | Animals | Protein Kinase Inhibitors - therapeutic use | Bone Marrow - pathology | Adolescent | Survival Analysis | Cell Line, Tumor | Glucose - metabolism | Aged | Mice | Protein Kinase Inhibitors - pharmacology | Index Medicus | Research Paper
Journal Article